MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer
- 327 Downloads
The aim of this study was to validate the role of MR/Ultrasound Fusion-Guided Targeted Biopsy as a first diagnostic modality in subjects with clinical suspicion of prostate cancer (PCa).
Materials and methods
108 men (age range 46–78 years) with clinical suspicion for PCa (PSA > 4 ng/mL) underwent multiparametric MRI of the prostate (mpMRI) and, when suspicious lesion were found (according to the PIRADSv2 scoring system), targeted biopsy was performed. All patients without significant alteration patterns at mpMRI have been referred for follow-up at 1 year.
91/108 patients showed on the mpMRI highly suspicious lesions (PIRADS 4 and 5); the remaining 17/108 patients revealed no significant alteration consistent with PCa (PIRADS 3). Among the first group of patients, 58/91 proved to be positive for PCa on the pathology report: 24 patients had a Gleason Score (GS) 6 (3 + 3); 18 patients GS 7 of which 7 (3 + 4) and 11 (4 + 3); 14 patients GS 8 (4 + 4); two patients GS 9 (5 + 4); 33 proved to be negative. Overall cancer detection rate (CDR) was 63%. However, the CDR rises significantly, up to 77%, after the 53 initial consecutive biopsies that were performed (p < 0,05) and thus identified as part of the learning curve. Patients of the second group (17/108) have been followed with serial PSA assessments, clinical reevaluation, and follow-up mpMRI.
Performing exclusively targeted MR/Ultrasound Fusion-Guided biopsies for the diagnosis of PCa in patients with suspicious PSA levels (> 4 ng/mL) increases the detection rate of clinically significant cancer, changing both the therapeutic options and the prognosis.
KeywordsProstate cancer Multiparametric magnetic resonance Targeted biopsy
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Jahn JL, Giovannucci EL, Stampfer MJ (2015) The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-era: high prostate cancer prevalence: research implications in the PSA-ERA. Int J Cancer 137(12):2795–2802CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Thompson J, Lawrentschuk N, Frydenberg M, Thompson L, Stricker P, USANZ (2013) The role of magnetic resonance imaging in the diagnosis and management of prostate cancer: The role of magnetic resonance imaging in the diagnosis and management of prostate cancer. BJU Int 112:6–20CrossRefPubMedGoogle Scholar
- 21.Mozer P et al (2015) First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer: mRI/TRUS-fusion targeted vs standard TRUS-guided biopsy. BJU Int. 115(1):50–57CrossRefPubMedGoogle Scholar
- 30.Salami SS et al (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?: performance of mpMRI in predicting prostate cancer on repeat biopsy. BJU Int. 115(4):562–570CrossRefPubMedGoogle Scholar
- 34.Schoots IG, Roobol MJ, Nieboer D, Bangma CH, Steyerberg EW, Hunink MGM (2015) Magnetic Resonance Imaging? targeted Biopsy May enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. Eur Urol 68(3):438–450CrossRefPubMedGoogle Scholar
- 40.Pokorny MR et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound? guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66(1):22–29CrossRefPubMedGoogle Scholar